-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Context Therapeutics Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q3 2020 to Q3 2025.
- Context Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 95,185,187, a 18% increase year-over-year.
- Context Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 58,416,141, a 266% increase from 2023.
- Context Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 15,966,053, unchanged from 2022.
- Context Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 15,966,053, a 463% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)